What guides our decisions — for patients, partners, and the scientific community.
By re-establishing physiological intraventricular flow patterns, Mythralica improves left-ventricular efficiency and preserves energetics across the cardiac cycle.
Conventional circular valves disrupt physiological flow and create zones of stagnation. Mythralica’s optimized geometry minimizes flow separation and turbulence, aiming to lessen dependence on chronic anticoagulation therapy.
The left-ventricular vortex is not merely a flow pattern, it is a functional mechanism for maintaining endocardial washout and conserving mechanical energy. Mythralica restores this physiological phenomenon, supporting the heart’s intrinsic fluid-dynamic balance.
By restoring near-physiologic hemodynamics, Mythralica aims to sustain ventricular efficiency, reduce flow-related complications, and preserve long-term cardiac performance.
“For more than six decades, mitral valve replacement has followed a flawed anatomical premise — treating the mitral valve as if it were a second aortic valve. The two are fundamentally distinct.
The mitral valve’s asymmetric leaflets and subvalvular apparatus exist to generate a left-ventricular vortex — not as a by-product, but as the core mechanism that conserves energy and enables efficient diastolic filling and systolic ejection. Conventional prostheses abolish this mechanism, forcing the ventricle to function under non-physiologic flow conditions.
VORTICA was conceived from first principles of cardiac physics rather than prosthetic convention. It is not merely a redesigned valve — it is a re-engineered flow system intended to restore the heart’s physiological vortex and its intrinsic energy efficiency.”
Mohammad Sarraf, MD